Hang Ta

Heart Foundation Future Leader Fellow - Group Leader
The Unviersity of Queensland

Brisbane, QLD

Contact me for

  • mentoring
  • sitting on boards or committees
  • providing an expert opinion
  • outreach activities
  • conference presenting
  • opportunities to collaborate

Biography

Dr. Hang Ta holds joint appointments at School of Pharmacy and Australian Institute for Bioengineering and Nanotechnology, the University of Queensland.  She currently leads a team of 9 students working on nanomaterials for diagnosis and treatment of cardiovascular diseases.

Expertise: Dr Hang Ta’s research addresses solutions for current problems in diagnosis and treatment of diseases. She is a pioneering bio-nanomaterials researcher developing innovative nanomaterials and magnetic resonance imaging (MRI) nanosensors for molecular imaging and drug delivery for cardiovascular disease in Australia. Dr Hang Ta’s team has great expertise in the full suite of forefront material synthesis and characterization techniques, and is skilled in the design of molecular imaging agents and drug delivery systems based on metal oxide and biocompatible polymers.

Awards and Funding: Dr Hang Ta has been awarded a number of prizes, grants and prestigious fellowships such as National Heart Foundation fellowships, NHMRC ECR fellowship and grants. She has secured over $2.5 million in competitive grant funding from national funding agencies for both discovery and infrastructure projects. Her recent NHMRC project grant award has enabled her to establish her research group of 9 students to work in the area of nanomaterials for cardiovascular disease.

Research Outputs and Impacts: Dr Ta has published papers in journals with high impact factor such as Nature Protocols, Circulation Research,  Biomaterials and Journal of Controlled Release with more than 1320 citations. Her research on iron oxide nanoparticles for molecular imaging of thrombosis was highlighted on cover page of Circulation Research, a second-ranked journal in the field of cardiovascular research.


Hang identifies as culturally and linguistically diverse.